PDB Short entry for 3S3S HEADER TRANSFERASE/TRANSFERASE INHIBITOR 18-MAY-11 3S3S TITLE TRANSGLUTAMINASE 2 IN COMPLEX WITH A NOVEL INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 2-687; COMPND 5 SYNONYM: TISSUE TRANSGLUTAMINASE, TRANSGLUTAMINASE C, TG(C), TGC, COMPND 6 TGASE C, TRANSGLUTAMINASE H, TGASE H, TRANSGLUTAMINASE-2, TGASE-2; COMPND 7 EC: 2.3.2.13; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: PEPTIDE INHIBITOR; COMPND 11 CHAIN: B; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TGM2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 11 ORGANISM_TAXID: 32630 KEYWDS TRANSGLUTAMINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR I.LINDEMANN,A.HEINE,G.KLEBE REVDAT 2 13-SEP-23 3S3S 1 REMARK SEQADV LINK REVDAT 1 06-JUN-12 3S3S 0 JRNL AUTH I.LINDEMANN,J.BOETTCHER,K.OERTEL,J.WEBER,M.HILS, JRNL AUTH 2 R.PASTERNACK,A.HEINE,G.KLEBE JRNL TITL INHIBITORS OF TRANSGLUTAMINASE 2: A THERAPEUTIC OPTION IN JRNL TITL 2 CELIAC DISEASE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7_650) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.03 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.0 REMARK 3 NUMBER OF REFLECTIONS : 32911 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.230 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.297 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1649 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.0442 - 5.2648 0.87 2818 134 0.2552 0.2976 REMARK 3 2 5.2648 - 4.1796 0.77 2305 120 0.2049 0.2572 REMARK 3 3 4.1796 - 3.6515 0.87 2575 158 0.2031 0.2906 REMARK 3 4 3.6515 - 3.3177 0.93 2710 149 0.2148 0.2851 REMARK 3 5 3.3177 - 3.0800 0.95 2749 153 0.2241 0.3111 REMARK 3 6 3.0800 - 2.8984 0.95 2754 144 0.2201 0.2961 REMARK 3 7 2.8984 - 2.7532 0.95 2728 130 0.2251 0.3297 REMARK 3 8 2.7532 - 2.6334 0.94 2717 152 0.2252 0.3343 REMARK 3 9 2.6334 - 2.5320 0.93 2673 125 0.2294 0.2616 REMARK 3 10 2.5320 - 2.4447 0.92 2624 158 0.2489 0.3550 REMARK 3 11 2.4447 - 2.3682 0.87 2509 127 0.2659 0.3210 REMARK 3 12 2.3682 - 2.3005 0.74 2100 99 0.2700 0.3432 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.95 REMARK 3 K_SOL : 0.36 REMARK 3 B_SOL : 62.50 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.950 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 9.16390 REMARK 3 B22 (A**2) : 9.16390 REMARK 3 B33 (A**2) : -18.32790 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4957 REMARK 3 ANGLE : 1.054 6752 REMARK 3 CHIRALITY : 0.066 765 REMARK 3 PLANARITY : 0.005 865 REMARK 3 DIHEDRAL : 14.919 1753 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3S3S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-MAY-11. REMARK 100 THE DEPOSITION ID IS D_1000065724. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-OCT-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR KMC REMARK 200 -2 REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-225 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34641 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07500 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 23.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.35 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.34500 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2Q3Z REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.93 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 3.0 M AMM. SULFATE, 0.1 M HEPES, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 289K, PH 7.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 155.17000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 35.71950 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 35.71950 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 77.58500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 35.71950 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 35.71950 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 232.75500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 35.71950 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 35.71950 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 77.58500 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 35.71950 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 35.71950 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 232.75500 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 155.17000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE MAIN POLYMERIC PROTEIN-GLUTAMINE GAMMA- REMARK 300 GLUTAMYLTRANSFERASE 2 IS A MONOMER IN THE ABSENCE OF THE PEPTIDE REMARK 300 INHIBITOR REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE UNREACTED FORM OF THE PEPTIDE INHIBITOR, CHAIN B HAS A DOUBLE REMARK 400 BOND BETWEEN C15 AND C17 OF THE AMINOACID XW1. UPON REACTION WITH REMARK 400 PROTEIN, A COVALENT BOND BETWEEN C15 AND SG OF CYS 277 CHAIN A IS REMARK 400 FORMED REMARK 400 REMARK 400 THE N-[(2R)-2-{[(BENZYLOXY)CARBONYL]AMINO}-7-ETHOXY-7-OXOHEPTANOYL]- REMARK 400 L-VALYL-L-PROLYL-L-LEUCINE IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: N-[(2R)-2-{[(BENZYLOXY)CARBONYL]AMINO}-7-ETHOXY-7- REMARK 400 OXOHEPTANOYL]-L-VALYL-L-PROLYL-L-LEUCINE REMARK 400 CHAIN: B REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -6 REMARK 465 ALA A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 HIS A 0 REMARK 465 ASP A 232 REMARK 465 GLY A 239 REMARK 465 ARG A 240 REMARK 465 TRP A 241 REMARK 465 ASP A 242 REMARK 465 ASN A 243 REMARK 465 ASN A 244 REMARK 465 TYR A 245 REMARK 465 GLY A 246 REMARK 465 ASP A 247 REMARK 465 GLY A 248 REMARK 465 VAL A 249 REMARK 465 SER A 250 REMARK 465 PRO A 251 REMARK 465 MET A 252 REMARK 465 HIS A 267 REMARK 465 GLY A 268 REMARK 465 CYS A 269 REMARK 465 GLN A 270 REMARK 465 ARG A 271 REMARK 465 VAL A 272 REMARK 465 LYS A 273 REMARK 465 TYR A 274 REMARK 465 GLY A 275 REMARK 465 GLN A 276 REMARK 465 ASP A 306 REMARK 465 GLN A 307 REMARK 465 ASN A 308 REMARK 465 ASN A 318 REMARK 465 GLU A 319 REMARK 465 PHE A 320 REMARK 465 GLY A 321 REMARK 465 GLU A 322 REMARK 465 ILE A 323 REMARK 465 GLN A 324 REMARK 465 GLY A 325 REMARK 465 ASP A 326 REMARK 465 LYS A 327 REMARK 465 GLN A 362 REMARK 465 GLU A 363 REMARK 465 LYS A 364 REMARK 465 SER A 365 REMARK 465 GLU A 366 REMARK 465 GLY A 367 REMARK 465 THR A 368 REMARK 465 TYR A 369 REMARK 465 GLN A 407 REMARK 465 ASP A 408 REMARK 465 ASP A 409 REMARK 465 GLY A 410 REMARK 465 SER A 411 REMARK 465 VAL A 412 REMARK 465 HIS A 413 REMARK 465 LEU A 462 REMARK 465 ASN A 463 REMARK 465 LYS A 464 REMARK 465 LEU A 465 REMARK 465 ALA A 466 REMARK 465 GLU A 467 REMARK 465 LYS A 468 REMARK 465 GLU A 469 REMARK 465 GLU A 470 REMARK 465 THR A 471 REMARK 465 ILE A 684 REMARK 465 GLY A 685 REMARK 465 PRO A 686 REMARK 465 ALA A 687 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 28 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 29 CG CD OE1 OE2 REMARK 470 LYS A 30 CG CD CE NZ REMARK 470 GLU A 85 CG CD OE1 OE2 REMARK 470 ASP A 97 CG OD1 OD2 REMARK 470 GLU A 120 CG CD OE1 OE2 REMARK 470 LYS A 173 CG CD CE NZ REMARK 470 LYS A 176 CG CD CE NZ REMARK 470 ILE A 178 CG1 CG2 CD1 REMARK 470 ASP A 233 CG OD1 OD2 REMARK 470 GLN A 234 CG CD OE1 NE2 REMARK 470 ARG A 317 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 414 CG CD CE NZ REMARK 470 ARG A 433 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 501 CG CD OE1 OE2 REMARK 470 GLU A 549 CG CD OE1 OE2 REMARK 470 LYS A 550 CG CD CE NZ REMARK 470 GLU A 557 CG CD OE1 OE2 REMARK 470 ILE A 572 CG1 CG2 CD1 REMARK 470 ARG A 592 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 596 CG CD OE1 OE2 REMARK 470 LYS A 598 CG CD CE NZ REMARK 470 LYS A 600 CG CD CE NZ REMARK 470 ARG A 601 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 602 CG CD CE NZ REMARK 470 GLU A 631 CG CD OE1 OE2 REMARK 470 LYS A 634 CG CD CE NZ REMARK 470 MET A 652 CG SD CE REMARK 470 LEU A 655 CG CD1 CD2 REMARK 470 LEU A 657 CG CD1 CD2 REMARK 470 MET A 659 CG SD CE REMARK 470 LYS A 674 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 XW1 B 2 C VAL B 3 N 0.143 REMARK 500 VAL B 3 C PRO B 4 N 0.151 REMARK 500 PRO B 4 C LEU B 5 N 0.141 REMARK 500 LEU B 5 C LEU B 5 O 0.126 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 125 -10.25 92.12 REMARK 500 GLN A 169 -157.16 -149.28 REMARK 500 ASN A 206 80.39 -172.90 REMARK 500 CYS A 230 89.85 -65.04 REMARK 500 GLN A 234 -42.50 73.66 REMARK 500 GLU A 329 56.27 -108.62 REMARK 500 ILE A 405 67.19 -102.63 REMARK 500 ASN A 573 47.96 81.18 REMARK 500 PRO A 597 77.60 -62.08 REMARK 500 GLN A 599 -11.36 -46.08 REMARK 500 LYS A 600 -97.81 -70.14 REMARK 500 LYS A 602 111.87 70.36 REMARK 500 LEU A 629 -63.15 -129.45 REMARK 500 PRO A 656 100.69 -31.09 REMARK 500 LEU A 657 -77.75 -48.52 REMARK 500 HIS A 658 -131.31 -118.28 REMARK 500 MET A 659 -65.73 -100.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 688 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 689 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 690 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 691 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 692 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 693 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF PEPTIDE INHIBITOR REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2Q3Z RELATED DB: PDB REMARK 900 TRANSGLUTAMINASE 2 UNDERGOES A LARGE CONFORMATIONAL CHANGE UPON REMARK 900 ACTIVATION REMARK 900 RELATED ID: 3S3J RELATED DB: PDB REMARK 900 TRANSGLUTAMINASE 2 IN COMPLEX WITH A NOVEL INHIBITOR REMARK 900 RELATED ID: 3S3P RELATED DB: PDB REMARK 900 TRANSGLUTAMINASE 2 IN COMPLEX WITH A NOVEL INHIBITOR DBREF 3S3S A 2 687 UNP P21980 TGM2_HUMAN 2 687 DBREF 3S3S B 1 5 PDB 3S3S 3S3S 1 5 SEQADV 3S3S MET A -6 UNP P21980 INITIATING METHIONINE SEQADV 3S3S ALA A -5 UNP P21980 EXPRESSION TAG SEQADV 3S3S HIS A -4 UNP P21980 EXPRESSION TAG SEQADV 3S3S HIS A -3 UNP P21980 EXPRESSION TAG SEQADV 3S3S HIS A -2 UNP P21980 EXPRESSION TAG SEQADV 3S3S HIS A -1 UNP P21980 EXPRESSION TAG SEQADV 3S3S HIS A 0 UNP P21980 EXPRESSION TAG SEQADV 3S3S HIS A 1 UNP P21980 EXPRESSION TAG SEQRES 1 A 694 MET ALA HIS HIS HIS HIS HIS HIS ALA GLU GLU LEU VAL SEQRES 2 A 694 LEU GLU ARG CYS ASP LEU GLU LEU GLU THR ASN GLY ARG SEQRES 3 A 694 ASP HIS HIS THR ALA ASP LEU CYS ARG GLU LYS LEU VAL SEQRES 4 A 694 VAL ARG ARG GLY GLN PRO PHE TRP LEU THR LEU HIS PHE SEQRES 5 A 694 GLU GLY ARG ASN TYR GLU ALA SER VAL ASP SER LEU THR SEQRES 6 A 694 PHE SER VAL VAL THR GLY PRO ALA PRO SER GLN GLU ALA SEQRES 7 A 694 GLY THR LYS ALA ARG PHE PRO LEU ARG ASP ALA VAL GLU SEQRES 8 A 694 GLU GLY ASP TRP THR ALA THR VAL VAL ASP GLN GLN ASP SEQRES 9 A 694 CYS THR LEU SER LEU GLN LEU THR THR PRO ALA ASN ALA SEQRES 10 A 694 PRO ILE GLY LEU TYR ARG LEU SER LEU GLU ALA SER THR SEQRES 11 A 694 GLY TYR GLN GLY SER SER PHE VAL LEU GLY HIS PHE ILE SEQRES 12 A 694 LEU LEU PHE ASN ALA TRP CYS PRO ALA ASP ALA VAL TYR SEQRES 13 A 694 LEU ASP SER GLU GLU GLU ARG GLN GLU TYR VAL LEU THR SEQRES 14 A 694 GLN GLN GLY PHE ILE TYR GLN GLY SER ALA LYS PHE ILE SEQRES 15 A 694 LYS ASN ILE PRO TRP ASN PHE GLY GLN PHE GLU ASP GLY SEQRES 16 A 694 ILE LEU ASP ILE CYS LEU ILE LEU LEU ASP VAL ASN PRO SEQRES 17 A 694 LYS PHE LEU LYS ASN ALA GLY ARG ASP CYS SER ARG ARG SEQRES 18 A 694 SER SER PRO VAL TYR VAL GLY ARG VAL VAL SER GLY MET SEQRES 19 A 694 VAL ASN CYS ASN ASP ASP GLN GLY VAL LEU LEU GLY ARG SEQRES 20 A 694 TRP ASP ASN ASN TYR GLY ASP GLY VAL SER PRO MET SER SEQRES 21 A 694 TRP ILE GLY SER VAL ASP ILE LEU ARG ARG TRP LYS ASN SEQRES 22 A 694 HIS GLY CYS GLN ARG VAL LYS TYR GLY GLN CYS TRP VAL SEQRES 23 A 694 PHE ALA ALA VAL ALA CYS THR VAL LEU ARG CYS LEU GLY SEQRES 24 A 694 ILE PRO THR ARG VAL VAL THR ASN TYR ASN SER ALA HIS SEQRES 25 A 694 ASP GLN ASN SER ASN LEU LEU ILE GLU TYR PHE ARG ASN SEQRES 26 A 694 GLU PHE GLY GLU ILE GLN GLY ASP LYS SER GLU MET ILE SEQRES 27 A 694 TRP ASN PHE HIS CYS TRP VAL GLU SER TRP MET THR ARG SEQRES 28 A 694 PRO ASP LEU GLN PRO GLY TYR GLU GLY TRP GLN ALA LEU SEQRES 29 A 694 ASP PRO THR PRO GLN GLU LYS SER GLU GLY THR TYR CYS SEQRES 30 A 694 CYS GLY PRO VAL PRO VAL ARG ALA ILE LYS GLU GLY ASP SEQRES 31 A 694 LEU SER THR LYS TYR ASP ALA PRO PHE VAL PHE ALA GLU SEQRES 32 A 694 VAL ASN ALA ASP VAL VAL ASP TRP ILE GLN GLN ASP ASP SEQRES 33 A 694 GLY SER VAL HIS LYS SER ILE ASN ARG SER LEU ILE VAL SEQRES 34 A 694 GLY LEU LYS ILE SER THR LYS SER VAL GLY ARG ASP GLU SEQRES 35 A 694 ARG GLU ASP ILE THR HIS THR TYR LYS TYR PRO GLU GLY SEQRES 36 A 694 SER SER GLU GLU ARG GLU ALA PHE THR ARG ALA ASN HIS SEQRES 37 A 694 LEU ASN LYS LEU ALA GLU LYS GLU GLU THR GLY MET ALA SEQRES 38 A 694 MET ARG ILE ARG VAL GLY GLN SER MET ASN MET GLY SER SEQRES 39 A 694 ASP PHE ASP VAL PHE ALA HIS ILE THR ASN ASN THR ALA SEQRES 40 A 694 GLU GLU TYR VAL CYS ARG LEU LEU LEU CYS ALA ARG THR SEQRES 41 A 694 VAL SER TYR ASN GLY ILE LEU GLY PRO GLU CYS GLY THR SEQRES 42 A 694 LYS TYR LEU LEU ASN LEU ASN LEU GLU PRO PHE SER GLU SEQRES 43 A 694 LYS SER VAL PRO LEU CYS ILE LEU TYR GLU LYS TYR ARG SEQRES 44 A 694 ASP CYS LEU THR GLU SER ASN LEU ILE LYS VAL ARG ALA SEQRES 45 A 694 LEU LEU VAL GLU PRO VAL ILE ASN SER TYR LEU LEU ALA SEQRES 46 A 694 GLU ARG ASP LEU TYR LEU GLU ASN PRO GLU ILE LYS ILE SEQRES 47 A 694 ARG ILE LEU GLY GLU PRO LYS GLN LYS ARG LYS LEU VAL SEQRES 48 A 694 ALA GLU VAL SER LEU GLN ASN PRO LEU PRO VAL ALA LEU SEQRES 49 A 694 GLU GLY CYS THR PHE THR VAL GLU GLY ALA GLY LEU THR SEQRES 50 A 694 GLU GLU GLN LYS THR VAL GLU ILE PRO ASP PRO VAL GLU SEQRES 51 A 694 ALA GLY GLU GLU VAL LYS VAL ARG MET ASP LEU LEU PRO SEQRES 52 A 694 LEU HIS MET GLY LEU HIS LYS LEU VAL VAL ASN PHE GLU SEQRES 53 A 694 SER ASP LYS LEU LYS ALA VAL LYS GLY PHE ARG ASN VAL SEQRES 54 A 694 ILE ILE GLY PRO ALA SEQRES 1 B 5 PHQ XW1 VAL PRO LEU MODRES 3S3S XW1 B 2 ALA HET PHQ B 1 10 HET XW1 B 2 13 HET SO4 A 688 5 HET SO4 A 689 5 HET SO4 A 690 5 HET SO4 A 691 5 HET SO4 A 692 5 HET SO4 A 693 5 HETNAM PHQ BENZYL CHLOROCARBONATE HETNAM XW1 (2S)-2-AMINO-7-ETHOXY-7-OXOHEPTANOIC ACID HETNAM SO4 SULFATE ION FORMUL 2 PHQ C8 H7 CL O2 FORMUL 2 XW1 C9 H17 N O4 FORMUL 3 SO4 6(O4 S 2-) FORMUL 9 HOH *153(H2 O) HELIX 1 1 GLU A 13 HIS A 21 1 9 HELIX 2 2 THR A 23 CYS A 27 5 5 HELIX 3 3 SER A 152 VAL A 160 1 9 HELIX 4 4 GLY A 188 VAL A 199 1 12 HELIX 5 5 ASN A 200 ASN A 206 1 7 HELIX 6 6 ASN A 206 ARG A 214 1 9 HELIX 7 7 SER A 216 VAL A 228 1 13 HELIX 8 8 SER A 257 ASN A 266 1 10 HELIX 9 9 CYS A 277 GLY A 292 1 16 HELIX 10 10 ASN A 310 ARG A 317 1 8 HELIX 11 11 VAL A 376 GLU A 381 1 6 HELIX 12 12 ASP A 389 ASN A 398 1 10 HELIX 13 13 ILE A 439 LYS A 444 1 6 HELIX 14 14 SER A 449 HIS A 461 1 13 HELIX 15 15 LEU A 547 ARG A 552 1 6 HELIX 16 16 ASP A 553 LEU A 555 5 3 SHEET 1 A 4 VAL A 6 ASP A 11 0 SHEET 2 A 4 PHE A 39 GLU A 46 -1 O GLU A 46 N VAL A 6 SHEET 3 A 4 THR A 99 THR A 105 -1 O LEU A 102 N LEU A 41 SHEET 4 A 4 THR A 89 GLN A 95 -1 N THR A 91 O GLN A 103 SHEET 1 B 5 LEU A 31 ARG A 34 0 SHEET 2 B 5 GLY A 127 LEU A 138 1 O ILE A 136 N VAL A 33 SHEET 3 B 5 GLY A 113 THR A 123 -1 N LEU A 117 O GLY A 133 SHEET 4 B 5 ASP A 55 THR A 63 -1 N SER A 56 O SER A 122 SHEET 5 B 5 LYS A 74 PRO A 78 -1 O PHE A 77 N PHE A 59 SHEET 1 C 2 GLN A 164 GLY A 170 0 SHEET 2 C 2 ILE A 175 ASN A 181 -1 O LYS A 176 N GLN A 169 SHEET 1 D 6 VAL A 374 PRO A 375 0 SHEET 2 D 6 GLY A 353 LEU A 357 -1 N ALA A 356 O VAL A 374 SHEET 3 D 6 PHE A 334 MET A 342 -1 N VAL A 338 O LEU A 357 SHEET 4 D 6 THR A 295 ALA A 304 -1 N ASN A 300 O HIS A 335 SHEET 5 D 6 LEU A 420 LYS A 429 -1 O ILE A 421 N SER A 303 SHEET 6 D 6 ARG A 436 ASP A 438 -1 O GLU A 437 N THR A 428 SHEET 1 E 6 SER A 415 ILE A 416 0 SHEET 2 E 6 ASP A 400 TRP A 404 -1 N ASP A 403 O SER A 415 SHEET 3 E 6 SER A 574 TYR A 583 1 O TYR A 575 N ASP A 400 SHEET 4 E 6 LEU A 560 GLU A 569 -1 N ILE A 561 O LEU A 582 SHEET 5 E 6 TYR A 503 VAL A 514 -1 N ARG A 512 O LYS A 562 SHEET 6 E 6 LEU A 520 LEU A 534 -1 O LYS A 527 N LEU A 509 SHEET 1 F 3 MET A 473 ARG A 478 0 SHEET 2 F 3 PHE A 489 ASN A 497 -1 O THR A 496 N ALA A 474 SHEET 3 F 3 SER A 538 ILE A 546 -1 O ILE A 546 N PHE A 489 SHEET 1 G 3 LYS A 590 LEU A 594 0 SHEET 2 G 3 LEU A 603 GLN A 610 -1 O VAL A 604 N LEU A 594 SHEET 3 G 3 GLU A 647 LEU A 654 -1 O LEU A 654 N LEU A 603 SHEET 1 H 4 LYS A 634 ILE A 638 0 SHEET 2 H 4 CYS A 620 GLU A 625 -1 N CYS A 620 O ILE A 638 SHEET 3 H 4 HIS A 662 GLU A 669 -1 O VAL A 665 N GLU A 625 SHEET 4 H 4 VAL A 676 VAL A 682 -1 O ARG A 680 N LEU A 664 LINK SG CYS A 277 C15 XW1 B 2 1555 1555 1.78 LINK C1 PHQ B 1 N XW1 B 2 1555 1555 1.45 LINK C XW1 B 2 N VAL B 3 1555 1555 1.48 CISPEP 1 GLY A 372 PRO A 373 0 2.67 CISPEP 2 LYS A 387 TYR A 388 0 -0.17 SITE 1 AC1 2 LYS A 202 ARG A 222 SITE 1 AC2 3 LYS A 202 ARG A 209 TYR A 219 SITE 1 AC3 1 ARG A 80 SITE 1 AC4 5 ARG A 80 ASP A 81 ALA A 82 HOH A 764 SITE 2 AC4 5 HOH A 815 SITE 1 AC5 3 ARG A 478 VAL A 479 ARG A 580 SITE 1 AC6 4 SER A 68 GLN A 69 LYS A 74 HOH A 838 SITE 1 AC7 12 GLN A 169 GLY A 170 CYS A 277 SER A 303 SITE 2 AC7 12 MET A 330 ILE A 331 TRP A 332 ASN A 333 SITE 3 AC7 12 PHE A 334 HIS A 335 THR A 360 ASN A 517 CRYST1 71.439 71.439 310.340 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013998 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013998 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003222 0.00000